Articles tagged with Sleep Apnea
A study found that daytime sleepiness is associated with an increased risk of brain deposits of beta amyloid, a hallmark of Alzheimer's disease. Participants who reported excessive daytime sleepiness were nearly three times more likely to develop beta-amyloid deposition in their brains years later.
Researchers will investigate whether obstructive sleep apnea diagnosis and treatment improves stroke recovery or reduces the likelihood of another stroke. The study aims to determine whether future patients should be screened and treated for OSA to improve survival and recovery after a stroke.
A study published in Arthritis & Rheumatology found that people with obstructive sleep apnea have a higher risk of developing gout. The risk was highest one to two years after diagnosis and was seen in patients with normal body mass index, regardless of weight status.
A new study found that even mild sleep disturbances can lead to elevated blood pressure in women, with nearly three times more common than severe sleep disturbances. Women who slept for seven to nine hours a night were significantly more likely to have high blood pressure.
A recent study has found that poor sleep quality is an independent risk factor for atrial fibrillation (AF), which can lead to symptoms like heart palpitations and shortness of breath. The researchers also discovered that disruptions in sleep patterns, such as reduced REM sleep, predict a higher risk of AF.
A Loyola Medicine study found lax, rubbery eyelids in 53% of sleep apnea patients, associated with the most severe cases. Sleep apnea affects an estimated 34% of men and 17% of women, but up to 80% remain undiagnosed.
A study published in Nature and Science of Sleep found that concurrent elevations of haemoglobin A1c, C-reactive protein, and erythropoietin in the blood may indicate obstructive sleep apnea. These biomarkers proved superior to standard screening methods, particularly in non-obese males.
A recent study found that 56% of older Medicare beneficiaries are at high risk of obstructive sleep apnea, yet only 8% have been tested for it. Treatment was prescribed for 82% of participants after diagnosis.
A new study found that over half of older adults (56%) have a high risk of OSA, but only 8% have been tested, highlighting the need for increased evaluation and treatment.
The ATS Foundation and ResMed have partnered on a new two-year research fellowship to study sleep apnea and positive airway pressure. This funding will support future leaders in the sleep field and help patients with sleep apnea, a public health crisis that affects millions worldwide.
The American Academy of Sleep Medicine advises against using medical marijuana to treat sleep apnea due to unreliable delivery methods and insufficient evidence on its effectiveness and safety. Effective treatments like CPAP therapy are available from licensed medical providers.
Chronic sleep deprivation increases risk of motor vehicle crashes due to impaired cognitive function. The study found severe sleep apnea is associated with a 123% increased risk, while mild to moderate sleep apnea elevates the risk by 13%. Short sleep duration also contributes to crash risks.
Research found distinct changes in brain structures and concurrent symptoms that differed between men and women with sleep apnea. Women showed more regions of the superior frontal lobe thinning than men or control groups, linked to enhanced cognitive deficits.
A study of patients with obstructive sleep apnea found that non-adherent patients were three times more likely to be readmitted to the hospital within 30 days for any cause. Non-adherence to CPAP therapy is a significant risk factor for hospital readmissions, particularly cardiovascular events.
A recent study suggests that college-age football linemen may be at higher risk for sleep-disordered breathing due to their physical conditioning. The study compared data from football linemen and track athletes, finding that the linemen had significantly larger necks and increased risk for sleep apnea despite having less body fat.
Researchers have identified risk factors for sleep apnea during pregnancy, including frequent snoring and older maternal age. A calculator tool has been developed to help obstetric providers identify women at risk for the condition, enabling early referral for definitive testing.
Researchers found that sleep apnea after a stroke significantly increased the risk of experiencing another stroke or dying. The study also identified a strong association between Mexican-American ethnicity and a higher risk of recurrent stroke or death.
Researchers developed a synthetic cannabis-like drug that was safe and effective in treating obstructive sleep apnea. Participants in the trial had reduced apnea and decreased subjective sleepiness after taking the drug for six weeks.
A new study found that positive airway pressure therapy significantly improves both general and sleep-specific quality of life measures in patients with obstructive sleep apnea. The improvements were most notable in those who adhered to the treatment.
Researchers at Beth Israel Deaconess Medical Center identified specific neural circuitry responsible for rousing the brain of mice in simulated apnea conditions. The findings suggest that PBelCGRP cells wake up the brain and are necessary for arousal, providing a potential target for interventions to treat obstructive sleep apnea.
The American Academy of Sleep Medicine (AASM) has released a position statement on home sleep apnea testing, emphasizing the importance of a physician's involvement in diagnosing and treating obstructive sleep apnea. The guideline outlines conditions under which a home sleep apnea test can be used for diagnosis.
Chronic kidney disease is characterized by gradual loss of kidney function over time. Poor sleep duration and quality are associated with steeper declines in kidney function and increased risk of developing kidney failure.
Research proposes that ADHD may be associated with disruptions in the body's natural circadian rhythm, leading to symptoms like delayed sleep phase and increased alertness in the evening. This finding raises the possibility of treating ADHD through non-pharmacological methods such as light therapy and sleep pattern changes.
Researchers found that inflammation originating from abdominal fat precedes the development of sleep apnea in adolescence. Weight loss and anti-inflammatory medication have also been shown to reduce apnea severity. The study suggests biological-based interventions may be more effective for mild to moderate cases.
A new automated system for measuring nighttime oxygen levels could help diagnose sleep apnea in children who snore. The approach was most accurate for children with severe apnea and detected 90% of those with severe disease. The test is simple, inexpensive, and can be performed at home using a pulse oximeter.
Scientists suspect sleep apnea diminishes healthspan due to its link with age-related diseases, including non-alcoholic liver disease and Alzheimer's, prompting researchers to explore treatment options.
Patients who watched videos of themselves struggling to breathe while sleeping with sleep apnea used CPAP machines three hours more per night than those who saw no video. The effect was dramatic, with patients becoming determined to fix their condition after witnessing the severity of their own sleep apnea.
A Northwestern University study finds that having a purpose in life is associated with improved sleep quality, reduced sleep apnea, and restless leg syndrome in older adults. The research suggests that cultivating purpose through mindfulness therapies could be an effective drug-free strategy to improve sleep.
A new study reveals that men with sleep apnoea and insomnia have a higher prevalence and severity of depressive symptoms than those with either condition alone. The study found that 43% of men with both conditions had depression, compared to 22% with insomnia alone and 8% with sleep apnoea alone.
A new study suggests that dronabinol, an old pharmaceutical product, could be a potential treatment for obstructive sleep apnea. Researchers found that the drug reduced the frequency of apneas and hypopneas during sleep, decreased subjective sleepiness, and improved overall treatment satisfaction.
Two studies found strong associations between mild-to-moderate obstructive sleep apnea and increased risks of hypertension and diabetes. Young adults and middle-aged individuals with sleep apnea were more likely to develop these conditions.
A new, disposable diagnostic patch effectively detects obstructive sleep apnea across all severity levels, with a clinical agreement rate of 87.4%. The SomnaPatch weighs less than one ounce and records various physiological parameters while being comfortable and easy to use.
Newborns of mothers with sleep apnea have a higher risk of congenital anomalies and resuscitation at birth, with a 26% increased risk. Babies of mothers with sleep apnea are more likely to be admitted to the ICU or special care nursery.
A new study finds that severe obstructive sleep apnea is most common among African-American inner-city children from low-income families in Washington D.C. These children are also more likely to have a delayed diagnosis, highlighting the need for increased awareness and education to identify and treat the condition.
African Americans with sleep apnea and insomnia are rarely diagnosed, with only 2.1% of those with sleep apnea reporting a physician diagnosis. Higher body mass index, hypertension, diabetes, being male, and older age were associated with sleep apnea severity.
Researchers analyzed data from 1,863 participants and found a significant association between air pollution exposure and low sleep efficiency. The study suggests that improving air quality may be one way to enhance sleep health and reduce health disparities.
Researchers developed a decision-tree tool to screen women with gestational diabetes for obstructive sleep apnea. The study found that neck circumference was significantly larger in the OSA group, and having a neck circumference greater than 35.5 cm was associated with higher risk for sleep apnea.
A study of children with untreated sleep apnea found significant reductions in gray matter, particularly in regions related to movement, memory, and emotions. The findings suggest that early detection and therapy are crucial for preventing long-term brain damage and cognitive deficits.
The new guideline recommends that polysomnography be used for the diagnosis of obstructive sleep apnea in patients with significant cardiorespiratory disease or other complicating conditions. Home sleep apnea testing is recommended only for uncomplicated adult patients with increased risk of moderate to severe sleep apnea.
A study examining the optimal timing for screening sleep apnea in patients who have had a heart attack found that initial tests conducted shortly after hospitalization are somewhat unreliable. Repeating the test or delaying it until six months later may be necessary to make an accurate diagnosis and avoid unnecessary treatment.
A randomized controlled trial found that oral appliances significantly improved sleep quality and symptoms in patients with severe sleep apnea, but had no effect on endothelial function or blood pressure. The study suggests further research is needed to determine the impact of oral devices on cardiovascular health.
The US Preventive Services Task Force concludes that screening for obstructive sleep apnea (OSA) in asymptomatic adults lacks sufficient evidence to assess benefits and harms. Current evidence supports treatment with CPAP, but its applicability to screen-detected populations is unknown.
The American Academy of Sleep Medicine suggests screening patients with a high risk for obstructive sleep apnea (OSA) to identify undiagnosed cases and reduce the economic burden. Screening can be done by primary care providers, who can refer patients to specialists for further evaluation.
Researchers found that blocking the enzyme responsible for hydrogen sulfide production can prevent or reduce apneas during sleep. This approach has potential to help people with multiple forms of sleep-disordered breathing, including obstructive and central apneas.
The ACA expanded insurance coverage and access to care for patients with chronic medical conditions, but nearly 1 in 7 remained uninsured. Home sleep testing was found to be as effective as lab testing in managing obstructive sleep apnea.
Research presented at the American Heart Association's Scientific Sessions 2016 found that disrupted sleep, including insomnia, is independently associated with an increased risk of atrial fibrillation. The study analyzed data from three sources and showed a 26% higher risk for those who frequently woke up during the night.
A new study found that positive airway pressure (PAP) therapy for sleep apnea significantly improves patient-reported outcomes in hypertensive patients, including reduced daytime sleepiness, depressive symptoms, and fatigue severity. The study also showed consistent improvement even in resistant hypertension cases.
A new study suggests that CPAP therapy may help improve nocturnal gastroesophageal reflux symptoms in patients with obstructive sleep apnea. The mean heartburn score decreased by 62 percent among sleep apnea patients who were adherent to CPAP therapy.
A recent study published in The Lancet found that an implanted nerve stimulator significantly improves symptoms of central sleep apnea, reducing events per hour by half or more for 51% of patients. The device also showed improvement in other sleep measures and overall quality of life, with only minor discomfort reported.
The Sleep Apnea Cardiovascular Endpoints (SAVE) study found that nightly CPAP treatment did not reduce cardiovascular risk in patients with OSA. However, treatment improved well-being and quality of life for the participants.
Researchers identify the signaling cascade leading to apnea-associated hypertension and propose a new treatment method by inhibiting cystathionine-y-lyase enzyme. Blocking hydrogen sulfide synthesis can prevent carotid body activation and hypertension in sleep apnea patients.
Researchers at the University of Colorado Anschutz Medical Campus found that sleep apnea worsens non-alcoholic fatty liver disease in obese adolescents. The study, published in the Journal of Hepatology, suggests that obstructive sleep apnea and low nighttime oxygen levels can promote the progression of the disease.
A new analysis reveals the economic burden of undiagnosed sleep apnea in the US, with estimated annual costs including $86.9 billion in lost productivity and $30 billion in increased healthcare utilization. Treatment for sleep apnea can improve patient health and quality of life.
A recent literature review suggests that both sleep disorders and oversleeping may increase the risk of stroke. The review recommends screening for sleep disorders in people who have had a stroke or transient ischemic attack (TIA), as they may be more likely to experience negative outcomes. Additionally, treatment with continuous posit...
Research contradicts previous findings that link poor sleep quality to joint pain, instead showing no association with obstructive sleep apnea. The study highlights the need for further investigation into the relationship between pain and sleep apnea.
Resistant hypertension patients with sleep apnea are at higher risk of ischemic heart events and congestive heart failure compared to those without resistant hypertension. The study included 470,386 hypertensive individuals and found no significant differences in stroke and premature death risks between the two groups.
A six-fold increase in diagnosed sleep disorders among US veterans has been reported, with post-traumatic stress disorder (PTSD) experiencing the largest rate increases. The study found that veterans with cardiovascular disease or other chronic conditions also experienced higher rates of sleep disorder diagnoses.
A University of Michigan study found an association between obstructive sleep apnea and cognitive dysfunction in MS patients. Treating OSA with CPAP therapy may help improve cognitive function in these patients.
The hypoglossal nerve stimulation (HGNS) device shows promise for treating moderate to severe OSA who can't tolerate CPAP, with a 84% reduction in AHI and 11% increase in oxygen levels. The study replicates the success of previous clinical trials, offering an alternative option for patients.
CHF patients with predominant central sleep apnea (CSA) are at higher risk for death and unplanned hospitalization, particularly those in the most severe NYHA class. ASV therapy has been shown to be effective in treating CSA, but its impact on mortality rates remains unclear.